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Abstract
Background: Base-excision repair (BER) is a central DNA repair mechanism responsible for the maintenance of
genome integrity. Accordingly, BER defects have been implicated in cancer, presumably by precipitating cellular
transformation through an increase in the occurrence of mutations. Hence, tight adaptation of BER capacity is
essential for DNA stability. However, counterintuitive to this, prolonged exposure of cells to pro-inflammatory
molecules or DNA-damaging agents causes a BER deficiency by downregulating the central scaffold protein XRCC1.
The rationale for this XRCC1 downregulation in response to persistent DNA damage remains enigmatic. Based on
our previous findings that XRCC1 downregulation causes wide-ranging anabolic changes, we hypothesised that BER
depletion could enhance cellular survival under stress, such as nutrient restriction.
Results: Here, we demonstrate that persistent single-strand breaks (SSBs) caused by XRCC1 downregulation trigger
the integrated stress response (ISR) to promote cellular survival under nutrient-restricted conditions. ISR activation
depends on DNA damage signalling via ATM, which triggers PERK-mediated eIF2α phosphorylation, increasing
translation of the stress-response factor ATF4. Furthermore, we demonstrate that SSBs, induced either through
depletion of the transcription factor Sp1, responsible for XRCC1 levels, or through prolonged oxidative stress, trigger
ISR-mediated cell survival under nutrient restriction as well. Finally, the ISR pathway can also be initiated by
persistent DNA double-strand breaks.
Conclusions: Our results uncover a previously unappreciated connection between persistent DNA damage, caused
by a decrease in BER capacity or direct induction of DNA damage, and the ISR pathway that supports cell survival
in response to genotoxic stress with implications for tumour biology and beyond.
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Background
DNA damage is considered the molecular origin of
many pathophysiological processes such as ageing, neu-
rodevelopmental and neurodegenerative disorders, and
cancer [1–3]. Sources of DNA damage include a wide
variety of exogenous damaging agents. However, even in
the absence of exogenous noxious influences, DNA is
prone to spontaneous alterations, due to its chemical re-
activity in the aquatic milieu and reactive side-products
that are created by the cellular metabolism [4]. This
leads to a high level of DNA lesions even under physio-
logical ‘unstressed’ circumstances that are in constant
need of repair to avert potential mutagenic and cytotoxic
consequences [5]. Base-excision repair (BER) is a centrally
important DNA repair mechanism responsible for cor-
recting many of these small base lesions and single-strand
breaks [6]. BER is a highly coordinated process in which
the scaffold protein XRCC1 occupies a critical role due to
its ability to stabilise the two other core BER components
DNA polymerase β and DNA ligase III [7, 8]. Therefore,
depletion of XRCC1 leads to loss of the core BER machin-
ery, and cells deficient in XRCC1 display reduced DNA
repair which causes an accumulation of persistent DNA
damage and an increase in genomic instability [6, 9]. DNA
repair deficiencies have been strongly implicated in the
development of cancer, due to increased mutation rate,
interference with transcription, or generation of toxic
double-strand breaks (DSBs), all of which can lead to cel-
lular transformation [10–14]. Likewise, haploinsufficiency
in XRCC1 enhances formation of precancerous lesions
[15], and selective depletion of neural XRCC1 or Ape1,
another BER component, leads to the development of
brain tumours in mice [16, 17]. Moreover, expression of
XRCC1 has been shown to be decreased in various differ-
ent tumours, with lower XRCC1 levels associated with
higher proliferation and shorter overall survival [18–23].
Hence, to avoid deleterious consequences of mutations
and maintain DNA integrity, the capacity for DNA repair
has to be tightly adapted to cellular needs [24, 25].
Recently, we have demonstrated that prolonged expos-
ure to the pro-inflammatory cytokine TGFβ or reactive
oxygen species (ROS) causes a deficiency in BER by de-
creasing XRCC1 expression in human primary fibro-
blasts [26]. This decrease in XRCC1 levels resulted in a
lowered BER capacity and led to accumulation of per-
sistent DNA damage. Mechanistically, persistent DNA
damage was found to induce ATM-dependent degrad-
ation of the transcription factor Sp1, which controls
XRCC1 expression, therefore creating a BER deficiency
through decreasing transcription of XRCC1 [27]. Thus,
somewhat counterintuitive to what would be expected
for maintenance of DNA integrity in response to stress-
ful conditions, cellular BER capacity is curbed through
downregulation of XRCC1 in response to persistent
DNA damage. The rationale for this reduction of BER
capacity in response to persistent DNA damage remains
enigmatic.
We have previously shown that a BER deficiency,
brought about by downregulation of XRCC1 by siRNA,
induces wide-ranging gene-expression changes in cellu-
lar metabolism that are comparable to changes found in
tumours [28]. This reprogramming of cellular metabol-
ism led to anabolic changes upon BER deficiency and
was found to be at least partially dependent on the
stress-responsive transcription factor ATF4 [26, 28]. As
key component of the integrated stress response (ISR),
ATF4 is a transcription factor that induces metabolic ad-
aptations to stressful conditions to ensure survival [29].
As such, ATF4 mounts appropriate responses in response
to a variety of different stresses, including nutrient
deprivation, hypoxia, viral infections, and endoplasmic
reticulum stress, and it has been shown to have important
roles in cancer [30, 31]. Activation of the ATF4 and ISR in
response to these stressors is mediated through activation
of one of the stress-responsive eIF2α kinases GCN2, PERK,
HRI, or PKR, which in turn phosphorylate eIF2α. While
phosphorylation of eIF2α leads to a global repression of
translation, it selectively increases the translation of ATF4
due to alternate use of open reading frames in the 5′ region
of the ATF4 mRNA [30]. ATF4 controls expression of a
wide range of genes that allow adaptation of cells to stress-
ful surroundings to promote cell survival, e.g. via induction
of autophagy, but—depending on the context—can also in-
duce apoptosis [31].
Based on our observation that XRCC1-depletion
caused wide-ranging anabolic changes in cellular metab-
olism, we hypothesised that the downregulation of BER
in response to persistent stressful influences could en-
hance cellular survival under suboptimal conditions,
such as nutrient restriction. Here, we demonstrate that
persistent DNA damage, caused by a decrease in BER
capacity or direct induction of DNA damage, triggers ac-
tivation of the ISR pathway through ATM, PERK,
peIF2α, and ATF4 to enhance cellular survival under
nutrient-restricted conditions. Our results uncover a
previously unappreciated connection between the BER
capacity, persistent DNA damage signalling, and ISR,
constituting a novel mechanism to support cell survival
in response to genotoxic stress that has strong implica-
tions for tumour biology and beyond.
Results
XRCC1 KD imparts human fibroblasts with a survival
advantage in nutrient-restricted conditions
Why do persistently stressed cells lower the expression
of XRCC1? Based on our previous findings, we hypothe-
sised that the downregulation of BER capacity would
lead to a metabolic rewiring towards nutritional self-
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sufficiency that would be advantageous for cells to sur-
vive under nutrient-starved conditions. To test this hy-
pothesis, Tig-1 human primary fibroblasts were treated
with XRCC1 or control siRNA and reseeded into dishes
with medium containing varying amounts of foetal calf
serum (FCS) 24 h later. Cell morphology and density
were analysed 72 h after knockdown (KD) using phase-
contrast images. When grown in a medium containing
15 or 5% FCS, no obvious differences in cell number or
morphology were discernible between XRCC1 KD and
control cells (Fig. 1a, b, e, and Additional file 1, Figure
S1A and B). Interestingly, however, when FCS was
lowered to 1%, XRCC1 KD cells clearly displayed a
significantly higher cell number, a more elongated
fibroblast-like cell morphology, and less rounded and
floating cells compared to controls (Fig. 1c, d, e). KD ef-
ficiency and transcriptional response of known genes up-
regulated in response to XRCC1 KD (ACTA2, PALLD
[26]) were not affected by reseeding cells into the differ-
ent FCS conditions (Additional file 1, Figure S1C). These
results were validated using two additional siRNA se-
quences against XRCC1 (Additional file 2, Figure S2)
and in two other human primary fibroblast cell lines
(Additional files 3 and 4, Figures S3 and S4). The
Fig. 1 Selective survival advantage of XRCC1 KD cells in nutrient-restricted conditions. Phase-contrast images of Tig-1 cells treated with siControl
(a, c) or siXRCC1 (b, d) and grown in a medium containing 5% FCS (a, b) or 1% FCS (c, d). Images are from one representative experiment, with
four different fields randomly chosen per condition. Scale bar = 400 μm. e Quantification of relative cell area as shown in a–d, normalised to
siControl grown at 5% FCS. n = 4. Only statistically significant differences are indicated using asterisks. f Cell cycle analysis of siControl and
siXRCC1 cells cultured at 15%, 5%, and 1% FCS, respectively. Shown is the percentage of cells in the respective cell cycle phases. n = 3. Statistically
significant differences are indicated using asterisks. g Quantification of the percentage of cells in late apoptosis in siControl and siXRCC1 cells
cultured at 15%, 5%, and 1% FCS, respectively. n = 3. *p < 0.05. h Quantification of the percentage of necrotic cells in siControl and siXRCC1 cells
cultured at 15%, 5%, and 1% FCS, respectively. n = 3. n.s. not significant
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increased cell number of XRCC1 KD cells under low
FCS conditions could be due to either an increase in
proliferation, a decrease in apoptosis, or a combination
of both. To differentiate between these possibilities, we
analysed the cell cycle distribution of control and
XRCC1 KD cells grown in 1%, 5%, and 15% FCS, re-
spectively, using flow cytometry. As expected from pre-
vious findings [28], XRCC1 KD cells grown at 15% FCS
displayed a significant increase in G1 cells and a con-
comitant decrease in S-phase cells compared to controls,
suggesting that XRCC1 KD under these conditions
causes the cell cycle to slow down slightly by prolonging
the G1-phase, presumably due to the accumulation of
persistent DNA damage (Fig. 1f). Similarly to this, cell
cycle distribution at 5% still displayed significantly more
XRCC1 KD cells in G1 and slightly less in S-phase com-
pared to control cells. However, in cells grown at 1%
FCS, no differences in the percentage of cells in G1, S,
or G2 cell cycle phases could be detected between con-
trol and XRCC1 KD cells. Indeed, the amount of control
cells in G1 significantly increased and cells in S-phase
significantly decreased with lower FCS concentrations,
while the percentage of XRCC1 KD cells in the different
cell cycle phases remained stable throughout the differ-
ent FCS conditions. Thus, XRCC1 KD cells did not have
a proliferative advantage over control cells at low FCS
conditions. To understand whether apoptosis differed
between control and XRCC1 KD cells grown in low FCS,
we analysed the rate of apoptotic cells by Annexin V/propi-
dium iodide staining at 72 h after seeding into different
FCS-containing media. While no significant changes be-
tween control and siXRCC1 cells at 15% and 5% FCS could
be detected, there were significantly more late apoptotic
control cells than siXRCC1 cells when cultured at 1%
(Fig. 1g). A similar trend was observed with respect to nec-
rotic cells, but this difference did not reach statistical sig-
nificance (Fig. 1h). Of note, these values are likely to
strongly underestimate the real amount of dying cells in the
control situation, since most of the dead cells are already
lost before the analysis (Fig. 1c, d). The observed increase
in apoptotic cell death of control cells is also in accordance
with the phenotype, as the control clearly shows much
more rounded, detaching, and floating cells than the
XRCC1 KD (Fig. 1c, d). In summary, these results strongly
support the hypothesis that XRCC1 KD confers cells with a
survival advantage in nutrient-restricted conditions.
XRCC1 KD induces the integrated stress response through
PERK-peIF2α-ATF4 signalling to support cell survival in
nutrient-restricted conditions
BER depletion in fibroblasts through KD of XRCC1 has
been shown to induce transcription of ATF4 by a yet
unknown mechanism [26, 28]. ATF4 is a transcription
factor that can induce metabolic adaptations to stressful
conditions and thereby promote survival [29–31]. There-
fore, we asked whether the survival advantage of fibro-
blasts in nutrient-restricted conditions upon XRCC1 KD
depended on ATF4. At 5% FCS, depletion of ATF4 alone
or in combination with XRCC1 merely showed a slight
decrease in cell numbers compared to control cells, sug-
gesting that a baseline ATF4 level is required for optimal
cellular fitness (Additional file 5, Figure S5A-D). Strik-
ingly, when cultured at 1% FCS, combined KD of ATF4
and XRCC1 completely rescued the phenotype observed
with XRCC1 KD alone and was virtually indistinguish-
able from control cells (Fig. 2a–e). KD efficiency was not
influenced by FCS conditions, and functionality of the
ATF4 KD was further validated by a strong decrease in
expression of PSAT1, a known direct downstream target
of ATF4, as well as rescue of ACTA2 and PALLD ex-
pression, which are known to be upregulated after
XRCC1 KD through an ATF4-dependent mechanism
(Fig. 2f) [26]. It is important to note that these XRCC1
KD-induced changes on both transcript and protein
levels could be observed irrespective of the FCS condi-
tions, but the phenotype of increased survival over con-
trol cells only manifested upon FCS restriction (Fig. 2f
and data not shown). We conclude that increased cell
survival upon XRCC1 KD under nutrient-restricted con-
ditions depends on the transcription factor ATF4.
As a central effector of the ISR, ATF4 can be regulated
on the translational level by activation of the ISR [30]. To
determine whether XRCC1 KD resulted in an increase in
ATF4 protein levels, we analysed ATF4 levels in XRCC1
KD cells. Western blot analysis revealed a strong increase
of ATF4 protein upon XRCC1 KD (Fig. 3a), which was
further validated using two other siRNA sequences against
XRCC1 (Additional file 5, Figures S5E and F). We next
wondered whether XRCC1 KD could induce phosphoryl-
ation of eIF2α (peIF2α) and thereby increase ATF4 trans-
lation through activation of the ISR. In line with an
increase in ATF4 translation through activation of the ISR
by XRCC1 KD, Western blot analysis confirmed that
XRCC1 KD induced peIF2α (Fig. 3b). Of note, the extent
of peIF2α activation by XRCC1 KD was comparable with
its induction by the known ER-stress inducer Thapsigar-
gin. These results prompted the question, which of the
upstream kinases was responsible for XRCC1 KD-
mediated activation of the ISR that led to upregulation of
ATF4. GCN2 and PERK have been shown to be important
in response to amino acid and glucose starvation as well
as endoplasmic reticulum stress [32]. While ATF4 upregu-
lation upon XRCC1 KD was not altered by co-KD of
GCN2 (Fig. 3c and Additional file 5, Figure S5G), co-KD
of PERK completely abrogated ATF4 induction (Fig. 3d).
Importantly, co-KD of PERK with XRCC1 also annulled
the increased survival of XRCC1 KD cells at 1% FCS
(Fig. 3e–i). Similar results were obtained by inhibition of
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PERK using GSK2606414 in combination with XRCC1
KD (Additional file 6, Supplementary Figure S6) [33].
Hence, these findings suggest that XRCC1 KD-mediated
activation of the ISR proceeds through the PERK-peIF2α-
ATF4 signalling pathway, which manifests in a survival ad-
vantage of cells under nutrient restriction.
The XRCC1 KD-induced survival advantage in nutrient-
restricted conditions is induced through signalling of
persistent DNA single-strand breaks via ATM
Given the connection between depletion of XRCC1 and
the survival advantage in nutrient-restricted conditions
mediated through activation of the ISR, we sought to iden-
tify the mechanism by which XRCC1 KD could induce the
ISR. It is well established that XRCC1 KD induces persistent
DNA damage due to BER deficiency, which leads to poly-
ADP-ribose (PAR) formation [7, 8, 25, 26, 28, 34, 35]. In line
with this, XRCC1 KD cells displayed an increase in persist-
ent DNA damage as measured by the alkaline comet assay
(Fig. 4a), increased PAR formation (Fig. 4b), and phosphor-
ylation of ATM (Fig. 4c). Importantly, consistent with previ-
ous reports [35], XRCC1 KD Tig-1 cells did not accumulate
DSBs as evidenced by a lack of increase in γH2AX by West-
ern blot (Fig. 4d), no increase in DSBs as assessed by the
neutral comet assay (Fig. 4e), and no change in the number
of 53bp1 or γH2AX foci in the cell nuclei (Fig. 4f, g). There-
fore, we asked whether DNA damage signalling was in-
volved in the activation of the ISR upon XRCC1 KD. SSBs
Fig. 2 Selective survival advantage of XRCC1 KD cells under nutrient restriction depends on ATF4. Phase-contrast images of Tig-1 cells treated with
siControl (a), siXRCC1 (b), siATF4 (c), or siXRCC1 and siATF4 (d) and grown in a medium containing 1% FCS. Images are from one representative
experiment, with four different fields randomly chosen per condition. Scale bar = 400 μm. e Quantification of relative cell area as shown in a–d, normalised
to siControl grown at 1% FCS. n= 4. Only statistically significant differences are indicated using asterisks. f Relative mRNA levels of XRCC1, ATF4, PSAT1,
ACTA2, and PALLD after siXRCC1 in cells cultured at 15, 5, and 1% FCS, respectively, normalised to expression in the respective control cells. n= 4
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and DNA base damage have been shown to induce signal-
ling through PARP, ATM, and DNA PKcs [35–37]. Neither
inhibition of DNA PKcs nor PARP using two different inhib-
itors could rescue the increase in ATF4 expression upon
XRCC1 KD (Fig. 4h, i, and Additional file 7, Figure S7A). In
contrast, inhibition of ATM was able to rescue the induction
of ATF4 (Fig. 4j and Additional file 7, Figure S7B). ATM in-
hibition also rescued the increase in peIF2α upon XRCC1
KD (Fig. 4k). Importantly, while not affecting growth at 5%
FCS, ATM inhibition completely rescued the increased sur-
vival imparted by XRCC1 KD at 1% FCS (Fig. 4l–p and
Additional file 7, Figure S7C). Thus, increased survival in
nutrient-restricted conditions through activation of the ISR
by XRCC1 KD depends on signalling of SSBs by ATM.
Manipulation of the XRCC1 transcription factor Sp1,
single-strand breaks induced by low-level H2O2, and DNA
double-strand breaks induced by ionizing radiation also
activate the ISR-mediated cell survival under nutrient-
restricted conditions
We then wondered whether activation of the ISR could
also be triggered by other modalities that lead to a
Fig. 3 XRCC1 KD induces the integrated stress response through PERK to support survival under nutrient-restricted conditions. a–d
Representative Western blots of a ATF4 and XRCC1 levels after siXRCC1. The band specific for ATF4 is indicated with a dash. n = 3. b peIF2α after
siXRCC1 or Thapsigargin. Normalised peIF2α levels are shown below the lanes. n = 3. c ATF4 and XRCC1 after KD of XRCC1 and/or GCN2. The
band specific for ATF4 is indicated with a dash. Normalised levels of ATF4 are shown below the lanes. n = 3. d PERK and ATF4 after KD of XRCC1
and/or PERK. The band specific for ATF4 is indicated with a dash. Normalised levels of ATF4 are shown below the lanes. n = 3. e–h Phase-contrast
images of cells treated with e siControl, f siXRCC1, g siPERK, or h siXRCC1 and siPERK, and grown in medium containing 1% FCS. Images are from
one representative experiment with four different fields randomly chosen per condition. Scale bar = 400 μm. i Quantification of relative cell area
as shown in e–h, normalised to siControl grown at 1% FCS. n = 4. Only statistically significant differences are indicated using asterisks
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decrease in XRCC1 levels. Expression of XRCC1 is con-
trolled by the transcription factor Sp1, and depletion of
Sp1 leads to a deficiency in BER due to decreased tran-
scription of XRCC1 [27]. Consistent with this, KD of
Sp1 for 72 h led to a significant reduction of XRCC1
protein levels, as well as an increase in pATM, support-
ing the notion that Sp1 KD leads to persistent DNA
damage due to a depletion in XRCC1 protein levels
(Fig. 5a). Of note, Sp1 KD did not elevate γH2AX levels
(Fig. 5b). Accordingly, Sp1 KD also triggered an increase
in both ATF4 and peIF2α levels (Fig. 5c), suggesting that
the transcriptional downregulation of XRCC1 of ap-
proximately 40% (Fig. 5a) obtained by KD of Sp1 is suffi-
cient to trigger activation of the ISR. In line with this,
Sp1 KD cells displayed significantly increased survival
compared to siControl-treated cells when cultured at 1%
FCS, but not at 5% FCS (Fig. 5d–f, Additional file 8,
Figure S8A and B).
Next, we asked if the observed phenomenon could also
be elicited by direct induction of persistent DNA dam-
age. For this, we analysed ATF4 and peIF2α levels in
cells exposed to low levels of hydrogen peroxide (H2O2)
for 72 h, which caused a slight increase of SSBs com-
pared to control cells (Fig. 5g), but failed to induce DSBs
as assessed by the neutral comet (Fig. 5h) and γH2AX
levels (Fig. 5i). Exposure of cells to 25 or 50 μM H2O2
over 72 h led to an upregulation of ATF4 and peIF2α
protein, in accordance with an induction of the ISR by
persistent DNA damage (Fig. 5j). Of note, this treatment
also precipitated a decrease in XRCC1 protein levels
(Fig. 5j). Strikingly, such chronic exposure to low levels
of H2O2 before seeding into low FCS medium induced a
significant survival advantage in these cells compared to
control treated cells upon culture at 1% FCS (Fig. 5k–n).
Hence, persistent single-strand DNA damage brought
about by chronic exposure to low levels of H2O2 induces
an ISR-dependent selective survival advantage under
nutrient-restricted conditions.
Finally, since ATM is well-known to be activated upon
DSB formation by ionising radiation [38], we wondered
whether its activation by direct formation of DSBs could
also induce the ISR. Indeed, Tig-1 cells irradiated for
three consecutive days with doses of 0.5, 1, or 2 Gy, re-
spectively, displayed elevated levels of pATM as well as
peIF2α and ATF4 (Fig. 5o). Importantly, cells pre-
treated in this way with ionising radiation before reseed-
ing also displayed increased survival upon culture in 1%
FCS compared to control cells (Fig. 5p–t). From these
results, we conclude that activation of ATM through
DSBs also leads to induction of the ISR to support cell
survival under nutrient restriction.
Collectively, our data clearly demonstrate that persist-
ent DNA damage, as induced via downregulation of
XRCC1 or direct induction of SSBs or DSBs through
DNA-damaging agents, confers cells with a selective sur-
vival advantage in nutrient-restricted conditions through
an ATM-dependent activation of the ISR pathway in-
volving the PERK-peIF2α-ATF4 axis. As such, these re-
sults uncover a previously unappreciated connection
between the BER capacity, DNA damage signalling, and
the ISR, which supports cell survival in response to gen-
otoxic stress with strong implications for tumour biology
and other physiological conditions in which cells have
been shown to selectively decrease the levels of BER
components.
Discussion
As a mainstay of genome integrity, BER is a centrally im-
portant pathway to counteract DNA lesions that arise
due to constant exposure of living organisms to exogen-
ous and endogenous DNA-damaging agents. Hence,
tight adaptation of BER capacity to cellular needs is con-
sidered critically important, as both insufficient or un-
controlled repair activity could potentially lead to the
accumulation of DNA damage and mutations [6, 24, 25,
39]. Under most physiological circumstances, BER cap-
acity is sufficient to avoid accumulation of unrepaired
DNA damage. Acute genotoxic stress could lead to tem-
poral exhaustion of BER capacity, leading to delays in re-
pair of DNA damage, potentially giving rise to genetic
instability. Importantly, however, there are also numer-
ous physiological circumstances in which cells have been
described to selectively induce a BER deficiency [40–44].
While the general idea has been that downregulation of
(See figure on previous page.)
Fig. 4 The XRCC1 KD-induced activation of the ISR is mediated through signalling of persistent single-stranded DNA damage via ATM. a Alkaline
comet assay of siControl and siXRCC1 cells. b–d Representative Western blots of b PAR and XRCC1 after siXRCC1. The smear above 100 kDa
marker indicates PAR. c pATM and ATM after siXRCC1 using 3 different siRNA sequences. d γH2AX, Histone H3, XRCC1, and Tubulin in cells after
siXRCC1, or 4 Gy IR. e Neutral comet assay of cells treated after siControl, siXRCC1, or 4 Gy IR. n = 4. f, g Quantification of 53 bp1 (f) or γH2AX (g)
foci per nucleus in cells after 4 Gy IR, siControl, or siXRCC1. h–j Representative Western blots of h ATF4 in siControl or siXRCC1 cells treated with
Ly or DMSO; i ATF4 in siControl or siXRCC1 cells treated with KU, Olap, or DMSO; j ATF4 in siControl or siXRCC1 cells treated with ATMi or DMSO;
and k peIF2a in siControl or siXRCC1 cells treated with ATMi or DMSO. Normalised levels of ATF4 or peIF2α are shown below the lanes. l–o
Phase-contrast images of siControl (l, m) or siXRCC1 (n, o) cells treated with DMSO (l, n) or ATMi (m, o), grown in a medium containing 1% FCS.
Images are from one representative experiment, with four different fields randomly chosen per condition. Scale bar = 400 μm. p Quantification of
relative cell area as shown in l–o normalised to siControl + DMSO grown at 1% FCS. n = 3. For all quantifications, only statistically significant
differences are indicated using asterisks
Clementi et al. BMC Biology           (2020) 18:36 Page 8 of 15
Fig. 5 (See legend on next page.)
Clementi et al. BMC Biology           (2020) 18:36 Page 9 of 15
BER in these cells might ‘prime’ them for apoptosis or
removal by the immune system, evidence for this is still
inconclusive. Indeed, several aspects suggest a physio-
logical role for this transient attenuation of BER capacity
that goes beyond simple priming of cells for apoptosis
and removal, as outlined in the following. Circulating
monocytes have been shown to harbour a deficiency in
DNA repair due to downregulation of key repair pro-
teins [40, 45, 46]. However, dendritic cells or macro-
phages that are derived from these monocytic precursors
re-express the relevant repair proteins, becoming repair-
proficient again. It would quite simply not make much
sense to try and initially target all of these precursor
cells by default for apoptosis or removal by the immune
system as a step during their maturation even before
they have reached their final differentiation state. Simi-
larly, chronic hypoxia has been found to lead to a de-
crease in expression of several BER proteins, and human
spermatozoa harbour a ‘truncated BER pathway’ mani-
fested by the absence of XRCC1 and Ape1 [44]. Finally,
human primary fibroblasts that are exposed to pro-
longed treatments with pro-inflammatory cytokines or
oxidative stress strongly decrease their BER capacity due
to a downregulation of XRCC1 and other BER proteins
[25–27]. Importantly, human fibroblasts are considered
highly apoptosis-resistant, and to undergo senescence
much rather than apoptosis, and they can be maintained
in culture for extremely long periods in that state [47].
This is in line with the crucial role of fibroblasts to
maintain the organism’s structural integrity, because,
even in a post-replicative senescent state, fibroblasts are
still able to actively shape the extracellular matrix. This
would not be possible where damaged fibroblasts are
quickly eliminated through apoptosis or by the immune
system. Following up on the idea that the specific down-
regulation of BER capacity could serve a physiological
purpose, our work uncovers a previously unappreciated
connection between the BER, persistent DNA damage,
and the ISR that supports cell survival in response to
genotoxic stress. These findings have strong implications
for tumour biology in a variety of aspects. On the one
hand, these results could directly impact on cells in the
tumour microenvironment, the so-called cancer-associated
stroma, and especially cancer-associated fibroblasts (CAFs),
which are highly central players in the development and
progression of tumours [48, 49]. Here, persistent DNA
damage signalling could increase survival and self-
sufficiency of stromal tumour-supportive cells. Interest-
ingly, ROS has been shown to be a potent inducer of CAFs
[50]. In line with this, we have shown that persistent DNA
damage in fibroblasts leads to a secretory phenotype by
which fibroblasts are able to support growth and metastatic
ability of tumour cells [26]. Thus, we propose that under
stressful circumstances, such as protracted inflammation or
persistent ROS, DNA damage is induced in the tissue-
resident fibroblasts, which leads to ATM signalling that ini-
tiates ATF4-dependent metabolic reprogramming to in-
crease cellular self-sufficiency in nutrients, thereby enabling
these cells to survive even in nutrient-starved conditions.
Through this increased resilience, fibroblasts can still fulfil
their important structural roles in the organism, as they are
the main responsible for synthesis of the extracellular
matrix, that provides the structural scaffold for other cells
to grow on and mechanical properties that determine the
integrity of organs [51]. Such a resilience mechanism seems
important especially also for CAFs. Per definitionem, CAFs
are located closely adjacent to the epithelial tumour-
forming, rapidly dividing cancer cells. These cancer cells
have a huge demand in a wide variety of nutrients to sus-
tain their high proliferative rate, and they have been shown
to remodel the surrounding stroma in a way that increases
the delivery of such nutrients and other growth-promoting
molecules [48]. Specifically, CAFs have been found to take
up metabolic waste of cancer cells to produce metabolites
that in turn are secreted again to feed the tumour [52]. It is
thus thought that most of the ‘rich’ nutrients are drained
away from CAFs to support tumour growth, which results
in the necessity for CAFs to survive in a ‘starved’ environ-
ment. The observed downregulation of BER capacity in
fibroblasts exposed to a maintained pro-inflammatory
stimulation that induces CAF generation seems to thus
increase self-sufficiency of these cells, which would be
beneficial in a starved environment. In summary, our obser-
vations suggest the metabolic rewiring upon BER decline
(See figure on previous page.)
Fig. 5 Induction of ISR-mediated cell survival under nutrient-restricted conditions through KD of Sp1, direct SSBs induced by H2O2, or direct DSBs
induced by ionising radiation. a (left) Representative Western blot of pATM, Sp1, and XRCC1 levels after siSp1. (right) Quantification of XRCC1
levels shown on the left, n = 5. b, c Representative Western blot of b Sp1, Tubulin, γH2AX, and Histone H3, or c Sp1, ATF4, and peIF2α after siSp1.
Normalised levels of ATF4 and peIF2α are indicated. d–e Phase-contrast images of cells treated with siCon (d) or siSp1 (e), grown in a medium
containing 1% FCS. f Quantification of d and e, n = 4. g Alkaline comet assay of cells treated with 25 μM H2O2. h Neutral comet assay of cells pre-
treated with 25 μM or 50 μM H2O2 for three consecutive days, or 4 Gy IR 15 min prior to harvesting, respectively. n = 4. i, j Representative Western
blots of i γH2AX and Histone H3 or j XRCC1, ATF4, and peIF2α, in cells treated as in h. Normalised levels of XRCC1, ATF4, and peIF2α are
indicated. k–m Phase-contrast images of cells treated as in h prior to seeding into a medium containing 1% FCS. n Quantification of k–m. n = 4.
o Western blot of pATM, Tubulin, ATF4, and peIF2α in control cells or cells treated with 0.5, 1, or 2 Gy of IR on three consecutive days. Normalised
levels of ATF4 and peIF2α are indicated. p–s Phase-contrast images of control cells (p) or cells treated as in o prior to seeding into a medium
containing 1% FCS. t Quantification of p–s, n = 4
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after stressful insults to be a physiological response of fibro-
blasts to ensure their survival in nutrient-starved condi-
tions, in order to fulfil their principal role of maintaining
the structure of the organism. On the other hand, our find-
ings could also have implications for survival of pre-
malignant or malignant tumour cells, which are strongly
exposed to various different types of stress [31]. However,
the reaction of tumour cells to persistent DNA damage
with regard to activation of the ISR and their survival under
nutrient starvation remains to be addressed in the future.
Mechanistically, we found activation of the ISR by
XRCC1 depletion to depend on signalling of SSBs via
ATM, which activates PERK-mediated eIF2α phosphor-
ylation and increases translation of the transcription fac-
tor ATF4 (Figs. 3 and 4). Currently, it remains unclear
whether activation of PERK by ATM is direct or indir-
ect. Additionally, also other modalities that induced
SSBs (Sp1 KD and treatment with low levels of H2O2)
and even direct induction of DSBs using ionising radi-
ation led to the activation of the ISR-mediated survival
phenotype (Fig. 5). Interestingly, cell death that is ob-
served under acute exposure of control cells to nutrient-
starved conditions very much resembles the ‘foamy cell
death’ that has recently been described in response to
chronic ER stress [53]. Prevention of this form of cell
death also depends on PERK activation of peIF2α, simi-
larly to what we observe upon XRCC1 KD. Additionally,
this foamy cell death apparently seems to be driven by a
‘non-apoptotic’ mechanism, which would explain why
the quantification of apoptotic cells through Annexin V-
PI staining does fully recapitulate the extent of cell death
that is visible under nutrient-deprived conditions in con-
trol cells (Fig. 1). Indeed, it seems that the Annexin V-PI
staining only captures a very small proportion of the effect
that acute nutrient starvation has on the control cells. It
will be interesting to determine what exact mechanism
precipitates cell death under these conditions.
The transcription factor ATF4 has a dual role in cells
promoting either their adaptation to endure stress or the
induction of apoptosis [31]. The ATF4 dependence of
the metabolic reprogramming that we observed upon
both XRCC1 KD and induction of DSBs is nicely in line
with our previous findings demonstrating increased
ATF4 transcription after XRCC1 KD [28] as well as its
involvement in the transcription of several CAF markers
that are activated upon XRCC1 KD [26]. Hence, cells
with persistent DNA damage seem somehow to be able
to exploit ATF4, to reduce stress resulting from nutrient
limitation and benefit from its pro-survival effects. This
raises intriguing questions as to what exact ATF4-
dependent changes allow cells to thrive in nutrient-starved
conditions and why ATF4 promotes cellular survival after
persistent DNA damage under these conditions rather than
inducing apoptosis. A deeper understanding of these
mechanisms might also facilitate the identification of
pharmacological strategies to fine-tune ATF4 activity in dif-
ferent pathologies, such as cancer.
Conclusion
Our results uncover a previously unappreciated connec-
tion between persistent DNA damage, caused either by a
decrease in BER capacity or by direct induction of DNA
single-strand or double-strand breaks, and activation of
the ISR. Activation of the ISR by DNA damage relies on
phosphorylation of the DNA damage sensor protein
ATM, which leads to PERK-mediated eIF2α phosphoryl-
ation, increasing translation of the stress-response factor
ATF4. This mechanism supports cell survival in re-
sponse to genotoxic stress with strong implications for
tumour biology and beyond.
Methods
Cell culture
TIG-1, AG09319, and AG16409 primary human fibro-
blasts were purchased from Coriell and cultured under
standard conditions (37 °C, 5% CO2) in Gibco™ DMEM,
low glucose, GlutaMAX™ Supplement, pyruvate contain-
ing 15% foetal calf serum (FCS). For all treatments using
inhibitors, inhibitors were dissolved in DMSO, medium
was changed, and fresh inhibitor was added every 24 h.
The following inhibitors were used: PERKi GSK2606414
(MerckMillipore), used at 1 μM final concentration;
DNA-PKcsi LY294002 (Ly, MerckMillipore), used at
1 μM final concentration; ATMi Ku-60019 (ATMi, Sig-
maAldrich), used at 10 μM final concentration; and
PARPi Ku-0058948 (Ku; AxonMedChem) and Olaparib
(Olap; Selleck Chemicals), both used at 1 μM final con-
centration. As positive control to induce ER stress/
peIF2α/ATF4, cells were exposed for 3 h to 1 μM Thap-
sigargin (Sigma). To induce DNA double-strand breaks,
cells were irradiated using a Faxitron Cabinet X-ray sys-
tem Model RX-650 at the indicated IR doses.
siRNA transfection
Transfections with siRNA purchased from Eurogentec
or Thermo Fisher were carried out using Lipofectamine
RNAiMAX reagent (Invitrogen) according to the manu-
facturer’s specifications. Cells were analysed at indicated
time points after transfection. siRNA sequences used are
listed in Additional file 9, Table S1.
Analysis of cell growth in serum-restricted growth
conditions
106 cells were seeded into 10-cm dishes 24 h prior to
siRNA transfection in standard medium containing 15%
FCS. Twenty-four hours after transfection, cells were
washed and trypsinised with 1ml trypsin solution, and
trypsin was neutralised through addition of 2 ml of
Clementi et al. BMC Biology           (2020) 18:36 Page 11 of 15
DMEM containing 5% FCS. One ml of the cell solution
was distributed into each fresh 10-cm dish, containing
10ml of medium with different concentrations of FCS
(i.e. 15, 5, and 1%), and incubated another 72 h until
analysis. Images of random fields were obtained with a
phase-contrast microscope at ×10 magnification, and
cells were collected for further analysis. For experiments
involving pre-treatment of cells with H2O2 or IR, cells
were grown in 10-cm dishes in standard medium con-
taining 15% FCS for the duration of the pre-treatment.
Pre-treatment was performed thrice every 24 h using the
indicated doses of H2O2 or IR. For treatments with
H2O2, the medium was changed every time. Twenty-
four hours after the third round of pre-treatment, equal
numbers of cells were seeded into different FCS-
containing dishes as described above. To quantify the
relative cell area from phase-contrast images, the area
covered with cells was quantified after thresholding of
images to remove the background using ImageJ software.
For each experiment and data point, two to four inde-
pendent fields were quantified, and mean values were
calculated, which were then normalised to the respective
control. Every experiment was independently repeated
three to four times (n = 3 or 4), as indicated in the re-
spective figure legends. Data are expressed as individual
data points and mean ± SEM. Raw data can be found in
Additional file 12 Table S4.
qRT-PCR
Total RNA was purified using the RNeasy® Mini Kit by
QIAGEN according to the manufacturer’s protocol. Equal
amounts of RNA were reverse transcribed using the
BioRad iScript™ cDNA Synthesis Kit according to the
manufacturer’s protocol with the LabCycler (SensoQuest).
Quantitative real-time PCR (RT-qPCR) was performed
using the KAPA SYBR® FAST One-Step qRT-PCR Kit in a
total volume of 10 μl in duplicates on the CFX384 Touch™
Real-Time PCR detection system (Bio-Rad). The compara-
tive CT method was applied for quantification of gene ex-
pression, values were normalised against GAPDH and
B2M and the control, and results were expressed as fold
change in mRNA levels over control cells. Each experi-
ment was independently repeated between two and four
times as indicated in the figure legends, and data are
expressed as individual data points and mean ± SD.
Primers are detailed in Additional file 10 [54], Table S2,
and were ordered from Microsynth. Raw data can be
found in Additional file 12, Table S4.
Flow cytometry
For cell cycle analysis by FACS, trypsinised cells were
fixed in ice-cold 70% ethanol for at least 30 min at −
20 °C. To remove the fixation solution, cells were spun
5min at 250 rcf at 4 °C, and the supernatant was
discarded. Cells were then resuspended in phosphate-
buffered saline with 100 μg/ml of DNase free RNase A
(Sigma) and incubated at 37 °C for 30 min and further
stained with 10 μg/ml propidium iodide (Sigma). Sam-
ples were run on a Fortessa (BD Biosciences) and the
cell cycle distribution analysed using FlowJo V10.6.1.
Each experiment was independently repeated three
times. Data are mean ± SD of n = 3 independent experi-
ments and are expressed as individual data points and
mean ± SD. Analysis of apoptotic and necrotic cells was
performed with the Annexin V-FITC Apoptosis Staining/
Detection Kit (Abcam, ab14085) according to the manu-
facturer’s protocol. Briefly, cells treated as indicated were
washed and adherent cells trypsinised. Trypsin was neu-
tralised using serum containing medium, and 500,000 cells
were collected by centrifugation and resuspended in
500 μl 1X Binding Buffer. Five μl of Annexin V-FITC and
5 μl propidium iodide were added, and samples were incu-
bated at room temperature for 5min before acquisition
with FACS as detailed above. Each experiment was inde-
pendently repeated five times. Data are mean ± SD of n =
5 independent experiments and are expressed as individ-
ual data points and mean ± SD. Raw data can be found in
Additional file 12 Table S4.
Western blot
For Western blotting, unless otherwise stated, whole cell
extracts that were prepared from cells grown in 15%
FCS were used according to a procedure described pre-
viously [28]. 20 to 40 μg of total protein extract was sep-
arated on 4–20% Tris–Glycine gels (Novex) and
transferred onto Immobilon-FL polyvinylidene fluoride
(PVDF) membranes (Millipore) according to standard
procedures (Novex). Blots were probed with primary
antibodies detailed in Additional file 11 Table S3, and
secondary antibodies conjugated with Alexa Fluor 680
and IRDye 800CW (both Li-cor Biosciences). Detection
and quantification was performed using the Odyssey
CLX image analysis system (Li-cor Biosciences). Tubulin
or Histone H3 serves as the loading control. Each ex-
periment was independently repeated three to five times.
For quantification, protein levels were first normalised
to the loading control and then to the respective control
lane. Relative protein levels are indicated below the lanes
and refer to the blot that is pictured.
Alkaline comet assay
The alkaline comet assay was performed as described
[8]. Briefly, cells were harvested by trypsinisation, diluted
to a concentration of 2 × 105 cells/ml in medium, and
embedded on a microscope slide in 1% low-melting
agarose in phosphate-buffered saline (PBS) (Bio-Rad)
that was settled on ice. Slides were lysed in buffer con-
taining 2.5M NaCl, 100 mM ethylenediamine-tetraacetic
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acid (EDTA), 10 mM Tris–HCl pH 10.5, 1% (v/v) di-
methyl sulfoxide (DMSO), and 1% (v/v) Triton X-100
for 1 h at 4 °C. Slides were then incubated in the dark
for 30 min in cold electrophoresis buffer (300 mM
NaOH, 1 mM EDTA, 1% (v/v) DMSO, pH > 13) to allow
DNA unwinding prior to electrophoresis at 21 V for 25
min in the comet assay tank from Trevigen. Neutralisa-
tion of the slides was performed with 0.5M Tris–HCl
(pH 8.0). The slides were stained with SYBR Gold (Invi-
trogen) and analysed using the Open Comet plugin for
Fiji [55]. To quantify, a minimum of 50 cells were ana-
lysed per assay and condition, and the assay was re-
peated independently three to four (Fig. 4) times. All
individual data points from all repeats and their mean ±
SD are displayed.
Neutral comet assay
The neutral comet assay was performed as described in
[56]. Briefly, cell harvesting and embedding was performed
as described for the alkaline comet assay. As positive con-
trol, cells were irradiated with 4 Gy IR 15min prior to har-
vesting. Slides were lysed in buffer containing 2.5M NaCl,
100mM EDTA, 10mM Tris, and 1% N-laroylsarcosine,
pH 9.5, with freshly added 1% (v/v) DMSO and 0.5% (v/v)
Triton X-100 for 1 h at 4 °C in the dark. Slides were then
washed 3 times in electrophoresis buffer (300mM sodium
acetate, 100mM Tris–HCl, pH 8.3) and incubated for 1 h
in fresh electrophoresis buffer. Electrophoresis was per-
formed in fresh cold buffer for 1 h at 21 V (ca 120mA) in
the comet assay tank from Trevigen. Afterwards, slides
were rinsed 3 times with dH2O, immediately stained using
SYBR Gold (Invitrogen), and air dried. Analysis was per-
formed using the Open Comet plugin for Fiji. For each
data point, at least 50 cells were quantified per assay and
condition, and mean values were calculated. The experi-
ment was independently repeated 3–4 times. Data are
mean ± SD of the mean values from these independent
experiments, as indicated in the respective figure legends.
Raw data can be found in Additional file 12, Table S4.
Immunofluorescence
Cells were grown in 6-well plates on sterile 12-mm glass
coverslips and fixed with 4% paraformaldehyde (pH 8.0)
in PBS for 15 min at room temperature. After one wash
in PBS, permeabilisation was performed using 0.2% Tri-
ton X-100 in PBS for 5 min at room temperature,
followed by three washes in PBS. Primary and secondary
antibodies were diluted in DMEM with 10% FCS (53
bp1, rabbit, Abcam, 1:1000; γH2AX, mouse, Millipore, 1:
1000; anti-mouse Alexa Fluor 488, Thermo Scientific, 1:
400; anti-rabbit Alexa Fluor 594, Thermo Scientific, 1:
400) and incubated 1–2 h at room temperature. DNA
was stained using 4′,6-diamidino-2-phenylindole dihy-
drochloride (DAPI, 0.2 μg/ml). After 3 washes in PBS,
coverslips were mounted on glass slides using ProLong
Gold Antifade Mountant (Molecular Probes) and im-
aged. Automated detection and quantification of foci in
nuclei was performed using Fiji. The number of foci was
quantified in a minimum of 100 nuclei per condition,
with 2 independent repeats. All individual data points
from all repeats and mean ± SD are displayed.
Experimental design and statistical analysis
The exact sample size (n) for each experiment is indicated
in the respective figure legends. All statistical analysis, cal-
culation, and graphical display were performed with the
programme GraphPad Prism (www.graphpad.com). Statis-
tical testing of differences from 3 groups or more was per-
formed using one-way ANOVA followed by Bonferroni’s
multiple comparison test, while Student’s t test was ap-
plied when only two groups were compared. Significance
levels are *p < 0.05, **p < 0.01, and ***p < 0.001.
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